Dapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 Cells
出版年份 2021 全文链接
标题
Dapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 Cells
作者
关键词
-
出版物
Cells
Volume 10, Issue 6, Pages 1457
出版商
MDPI AG
发表日期
2021-06-11
DOI
10.3390/cells10061457
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats
- (2021) Krit Jaikumkao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells
- (2021) Nawel Zaibi et al. PLoS One
- Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
- (2021) Jin Kyung Seok et al. Frontiers in Immunology
- Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
- (2021) Ji-Yeon Lee et al. Diabetes & Metabolism Journal
- Interplay of adenosine monophosphate‐activated protein kinase/sirtuin‐1 activation and sodium influx inhibition mediates the renal benefits of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: A novel conceptual framework
- (2020) Milton Packer DIABETES OBESITY & METABOLISM
- Innate immunity in diabetic kidney disease
- (2020) Sydney C. W. Tang et al. Nature Reviews Nephrology
- Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetes
- (2020) Munehiro Kitada et al. Aging-US
- Role of Deranged Energy Deprivation Signaling in the Pathogenesis of Cardiac and Renal Disease in States of Perceived Nutrient Overabundance
- (2020) Milton Packer CIRCULATION
- Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors
- (2020) Milton Packer JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway
- (2020) Fengtao Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Empagliflozin alleviated mitochondrial fission via decreasing PGAM5.
- (2020) Xiangyang Liu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin protects heart from inflammation and energy depletion via AMPK activation
- (2020) Chintan N. Koyani et al. PHARMACOLOGICAL RESEARCH
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion
- (2020) Sergiy Sukhanov et al. CELLULAR SIGNALLING
- Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
- (2019) Shinsuke Sakai et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
- (2019) Keiichiro Matoba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus
- (2019) Weiling Leng et al. Annals of Translational Medicine
- The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure
- (2019) Deepak L. Bhatt et al. Cell Metabolism
- Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
- (2019) Ryoichi Bessho et al. Scientific Reports
- Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs
- (2019) Rong Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
- (2019) Nitin A. Das et al. CELLULAR SIGNALLING
- Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
- (2018) Chenke Xu et al. BIOCHEMICAL PHARMACOLOGY
- Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
- (2018) Krit Jaikumkao et al. DIABETES OBESITY & METABOLISM
- A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity
- (2018) Munehiro Kitada et al. Nutrition & Metabolism
- AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
- (2018) Mario D. Cordero et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Renoprotection of dapagliflozin in human renal proximal tubular cells via the inhibition of the high mobility group box 1‑receptor for advanced glycation end products‑nuclear factor‑κB signaling pathway
- (2018) Di Yao et al. Molecular Medicine Reports
- SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
- (2017) Daniel Garcia et al. MOLECULAR CELL
- The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
- (2016) Simon A. Hawley et al. DIABETES
- A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity
- (2016) Munehiro Kitada et al. DIABETOLOGIA
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
- (2016) Ralph A. DeFronzo et al. Nature Reviews Nephrology
- The NLRP3 inflammasome in kidney disease and autoimmunity
- (2016) Holly L Hutton et al. NEPHROLOGY
- Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
- (2016) Yuan-ye Qiu et al. PHARMACOLOGICAL RESEARCH
- Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study
- (2016) Michael A Weber et al. Lancet Diabetes & Endocrinology
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. DIABETES CARE
- Role of NF-κB in the pathogenesis of diabetes and its associated complications
- (2014) Sandip Patel et al. Pharmacological Reports
- Metabolism of inflammation limited by AMPK and pseudo-starvation
- (2013) Luke A. J. O'Neill et al. NATURE
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Involvement of Endoplasmic Reticulum Stress in Albuminuria Induced Inflammasome Activation in Renal Proximal Tubular Cells
- (2013) Li Fang et al. PLoS One
- SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells
- (2012) Ai Takeda-Watanabe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages
- (2012) Yu Qiao et al. FEBS LETTERS
- The pathogenic role of the renal proximal tubular cell in diabetic nephropathy
- (2012) S. C. W. Tang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Autophagy: Renovation of Cells and Tissues
- (2011) Noboru Mizushima et al. CELL
- Structure of mammalian AMPK and its regulation by ADP
- (2011) Bing Xiao et al. NATURE
- The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
- (2009) W. Lieberthal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now